{{Rsnum
|rsid=3787554
|Gene=CYP24A1
|Chromosome=20
|position=54166141
|Orientation=plus
|GMAF=0.1088
|Gene_s=CYP24A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 24.8 | 74.3
| HCB | 2.3 | 30.1 | 67.7
| JPT | 5.3 | 40.7 | 54.0
| YRI | 0.0 | 2.0 | 98.0
| ASW | 0.0 | 7.0 | 93.0
| CHB | 2.3 | 30.1 | 67.7
| CHD | 3.7 | 46.8 | 49.5
| GIH | 0.0 | 16.0 | 84.0
| LWK | 0.0 | 6.5 | 93.5
| MEX | 0.0 | 10.5 | 89.5
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 22.2 | 77.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23435876
|Title=A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}